Cubist Systematic Strategies, LLC Macrogenics Inc Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$9.77 - $21.47 $696,737 - $1.53 Million	71,314 Added 158.46%	116,317 $1.71 Million
Q4 2023 Feb 14, 2024	BUY	$4.48 - $10.11 $201,613 - $454,980	45,003 New	45,003 $432,000
Q1 2023 May 15, 2023	SELL	$4.82 - $7.24 $677,918 - $1.02 Million	-140,647 Reduced 49.03%	146,232 $1.05 Million
Q4 2022 Feb 14, 2023	BUY	$3.34 - $6.98 $364,774 - $762,313	109,214 Added 61.47%	286,879 $1.92 Million
Q3 2022 Nov 14, 2022	BUY	$3.01 - $5.22 $11,775 - $20,420	3,912 Added 2.25%	177,665 $615,000
Q2 2022 Aug 15, 2022	BUY	$2.25 - $9.99 $121,176 - $538,021	53,856 Added 44.92%	173,753 $513,000
Q1 2022 May 16, 2022	BUY	$8.12 - $16.9 $641,853 - $1.34 Million	79,046 Added 193.5%	119,897 $1.06 Million
Q4 2021 Feb 14, 2022	SELL	$15.91 - $21.88 $115,013 - $158,170	-7,229 Reduced 15.04%	40,851 $656,000
Q3 2021 Nov 15, 2021	BUY	$19.74 - $28.7 $692,341 - $1.01 Million	35,073 Added 269.65%	48,080 $1.01 Million
Q2 2021 Aug 16, 2021	BUY	$20.49 - $35.63 $8,585 - $14,928	419 Added 3.33%	13,007 $349,000
Q1 2021 May 17, 2021	SELL	$18.99 - $33.2 $53,874 - $94,188	-2,837 Reduced 18.39%	12,588 $401,000
Q4 2020 Feb 16, 2021	SELL	$19.41 - $26.0 $197,632 - $264,732	-10,182 Reduced 39.76%	15,425 $353,000
Q3 2020 Nov 16, 2020	SELL	$24.69 - $31.6 $1.1 Million - $1.41 Million	-44,669 Reduced 63.56%	25,607 $645,000
Q2 2020 Aug 14, 2020	BUY	$5.2 - $29.12 $363,220 - $2.03 Million	69,850 Added 16396.71%	70,276 $1.96 Million
Q1 2020 May 15, 2020	SELL	$4.28 - $12.11 $174,350 - $493,312	-40,736 Reduced 98.97%	426 $2,000
Q4 2019 Feb 14, 2020	BUY	$7.95 - $12.27 $273,972 - $422,848	34,462 Added 514.36%	41,162 $448,000
Q3 2019 Nov 14, 2019	SELL	$12.44 - $17.48 $681,724 - $957,921	-54,801 Reduced 89.11%	6,700 $85,000
Q2 2019 Aug 14, 2019	BUY	$14.51 - $19.71 $666,502 - $905,359	45,934 Added 295.07%	61,501 $1.04 Million
Q1 2019 May 15, 2019	BUY	$11.11 - $25.6 $49,095 - $113,126	4,419 Added 39.64%	15,567 $280,000
Q4 2018 Feb 14, 2019	SELL	$11.75 - $21.42 $97,642 - $178,000	-8,310 Reduced 42.71%	11,148 $142,000
Q3 2018 Nov 14, 2018	BUY	$19.26 - $23.46 $280,926 - $342,187	14,586 Added 299.38%	19,458 $417,000
Q2 2018 Aug 14, 2018	SELL	$19.78 - $24.67 $404,303 - $504,254	-20,440 Reduced 80.75%	4,872 $101,000
Q1 2018 May 15, 2018	BUY	$18.89 - $32.46 $347,878 - $597,783	18,416 Added 267.05%	25,312 $637,000
Q4 2017 Feb 14, 2018	BUY	$16.19 - $20.3 $110,027 - $137,958	6,796 Added 6796.0%	6,896 $131,000
Q3 2017 Nov 14, 2017	BUY	$15.52 - $18.94 $1,552 - $1,894	100	100 $2,000

Others Institutions Holding MGNX

# of Institutions

132

Shares Held

55.4M

Call Options Held

215K

Put Options Held

238K

Bellevue Group Ag Kuesnacht, V8

9.93M
Shares

$32.4 Million
0.55% of portfolio
Armistice Capital, LLC New York, NY

6.26M
Shares

$20.4 Million
0.34% of portfolio
Black Rock Inc. New York, NY

5.4M
Shares

$17.6 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

4.36M
Shares

$14.2 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.54M
Shares

$11.5 Million
0.01% of portfolio

View Full List

About MACROGENICS INC

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $200M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

More about MGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account